NTB-A Receptor Crystal Structure: Insights into Homophilic Interactions in the Signaling Lymphocytic Activation Molecule Receptor Family  by Cao, Erhu et al.
Immunity 25, 559–570, October 2006 ª2006 Elsevier Inc. DOI 10.1016/j.immuni.2006.06.020NTB-A Receptor Crystal Structure: Insights
into Homophilic Interactions in the Signaling
Lymphocytic Activation Molecule Receptor FamilyErhu Cao,1 Udupi A. Ramagopal,3 Alexander Fedorov,3
Elena Fedorov,3 Qingrong Yan,1 Jeffrey W. Lary,5
James L. Cole,5 Stanley G. Nathenson,1,2,*
and Steven C. Almo3,4,*
1Department of Cell Biology
2Department of Microbiology and Immunology
3Department of Biochemistry
4Department of Physiology and Biophysics
Albert Einstein College of Medicine
Bronx, New York 10461
5National Analytical Ultracentrifugation Facility
University of Connecticut
Biotechnology Bioservices Center Unit 3149
Storrs, Connecticut 06269-3149
Summary
The signaling lymphocytic activation molecule
(SLAM) family includes homophilic and heterophilic
receptors that regulate both innate and adaptive im-
munity. The ectodomains of most SLAM family mem-
bers are composed of an N-terminal IgV domain and
a C-terminal IgC2 domain. NK-T-B-antigen (NTB-A) is
a homophilic receptor that stimulates cytotoxicity in
natural killer (NK) cells, regulates bactericidal activi-
ties in neutrophils, and potentiates T helper 2 (Th2) re-
sponses. The 3.0 A˚ crystal structure of the complete
NTB-A ectodomain revealed a rod-like monomer that
self-associates to form a highly kinked dimer span-
ning an end-to-end distance of w100 A˚. The NTB-A
homophilic and CD2-CD58 heterophilic dimers show
overall structural similarities but differ in detailed
organization and physicochemical properties of their
respective interfaces. The NTB-A structure suggests
a mechanism responsible for binding specificity
within the SLAM family and imposes physical con-
straints relevant to the colocalization of SLAM-family
proteins with other signaling molecules in the immu-
nological synapse.
Introduction
Signaling lymphocytic activation molecule (SLAM)-fam-
ily receptors, SLAM, NK-T-B-antigen (NTB-A), CD84,
CD2-like receptor activating cytotoxic cells (CRACC),
Ly-9 and 2B4, are widely expressed on hematopoietic
cell surfaces and regulate both innate and adaptive
immunity (Engel et al., 2003; Veillette, 2006; Veillette
et al., 2006). The SLAM family is a subset of the greater
CD2 family that also includes CD2, CD48, and CD58.
The ectodomains of the CD2-family receptors share
a common architecture, composed of a membrane
distal IgV domain and a membrane proximal truncated
IgC2 domain. Ly-9 is the sole exception with two tandem
repeats of the fundamental IgV-IgC2 motif.
*Correspondence: almo@aecom.yu.edu (S.C.A.), nathenso@aecom.
yu.edu (S.G.N.)The cytoplasmic tails of the SLAM-family receptors
contain immunoreceptor tyrosine-based switch motifs
(ITSMs), which are docking sites for the SH2 domain of
SLAM-associated protein (SAP) and the related Ewing’s
sarcoma-associated transcript (EAT)-2 and EAT-2-re-
lated transducer (ERT) proteins (Latour and Veillette,
2004). SAP also binds to the SH3 domain of the Fyn ty-
rosine kinase, and formation of the SLAM-SAP-Fyn ter-
nary complex triggers a signaling cascade that results in
phosphorylation of SH2-containing inositol 50-phospha-
tase (SHIP), Downstream of tyrosine kinase (Dok)1,
Dok2, and Shc and ultimately inhibits interferon (IFN)-g
secretion in T cells (Latour et al., 2001). The SAP-Fyn
pathway also operates in natural killer (NK) cells and en-
hances cytotoxicity against tumor cells (Bloch-Queyrat
et al., 2005). The importance of SAP and the SLAM-
family receptors in immune regulation is further under-
scored by the finding that patients with defects in SAP
exhibit X-linked lymphoproliferative (XLP) disease, an
immunodeficiency characterized by the inability to con-
trol Epstein-Barr Virus (EBV) infection. In contrast to
SAP, EAT-2 and ERT both repress NK cell cytotoxicity
and IFN-g secretion (Roncagalli et al., 2005).
NTB-A, also denoted as Ly108, is expressed on a wide
range of immune cells and exerts a stimulatory effect on
NK cells, resulting in augmented cytotoxicity. SAP ap-
pears to be involved in NTB-A signaling in NK cells
because this stimulatory effect is impaired in NK cells
derived from XLP patients (Bottino et al., 2001). Further
insight into the immunoregulatory function of NTB-A has
been provided by the studies of NTB-A-deficient mice
(Howie et al., 2005). NTB-A-deficient CD4+ T cells pro-
duce substantially less IL-4 compared to wild-type
CD4+ T cells. Similar to SLAM-deficient (Wang et al.,
2004) and SAP-deficient (Czar et al., 2001; Wu et al.,
2001) mice, NTB-A-deficient mice also exhibit impaired
T helper 2 (Th2) responses, as evidenced by the finding
that their inflammatory responses to Leishmania mexi-
cana infection are not as severe as those exhibited by
wild-type mice. The analysis of NTB-A-deficient mice
also suggests a role for NTB-A in innate immune re-
sponses because NTB-A-deficient neutrophils demon-
strate impaired bactericidal activity as the consequence
of severely reduced production of reactive oxygen spe-
cies after phagocytosis of bacteria.
Extensive polymorphism in the CD2 gene cluster is
associated with systemic lupus erythematosus (SLE) in
mice. Specifically, lymphocytes isolated from B6 and
SLE-prone B6.Sle1b mice use distinct NTB-A splice
variants that encode proteins bearing either two or three
tyrosine-phosphorylation motifs. Because this differ-
ence in the composition of the cytoplasmic tail may
dramatically modulate the signaling capabilities of the
molecule, NTB-A is the strongest lupus susceptibility
candidate among four polymorphic members (CD48,
CD150, CD84, and NTB-A) from the CD2 family (Wand-
strat et al., 2004). Indeed, a recent study demonstrated
a significant NTB-A isoform-dependent effect on B-cell
tolerance (Kumar et al., 2006). Given the central role
that NTB-A plays in immune regulation, it represents
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560Table 1. Crystallographic Data, Phasing, and Refinement Statistics
Data Collection
Native Peak Inflection Remote
Source NSLS-X29 NSLS-X29 NSLS-X29 NSLS-X29
Wavelength (A˚) 1.071 0.9789 0.9791 0.9714
Resolution limits (A˚) 50–3.0 50–3.2 5–3.4 50–3.4
Space group C2 C2 C2 C2
Unit cell a, b, c (A˚) and b () 121.2, 148.5, 86.6, 112.9 120.2, 149.8, 86.3, 114.2 120.3, 149.9, 86.4, 114.2 119.8, 149.7, 86.2, 114.2
Number of observations 90298 111080 90161 93764
Number of unique
reflections
28402 44727e 37970e 37754e
Completeness (%) 99.7 (99.9)d 98.6 (91.1)d 99.2 (90.0)d 99.3 (98.3)d
Mean I/sI 16.5 (3.0)d 16.8 (2.0)d 12.7 (2.1)d 13.2 (2.5)d
Rmerge on I
a 5.9 (34.8)d 6.0 (40)d 7.2 (38.0)d 7.1 (33.8)d
Phasing
Number of sites found 11
FOM after SOLVE 0.37
FOM after RESOLVE 0.62
Refinement Statistics
Resolution limits (A˚) 40–3.0
Number of reflections
(work/test)
26738/1413
Rwork
b 0.216 (0.289)d
Rfree (5% of data) 0.266 (0.391)
d
Number of Atoms
Protein/H2O/Ca
2+/Cl2 5963/3/2/1
Mean B values (A˚2) main chains 82.9, side chains 84.2, H2O 83.6
RMSD from Ideality
Bonds (A˚)/Angles () 0.007/1.085c
Ramachandran plot 79.7% in most favored region, 17.9% in additionally allowed region, 1.9% in generously allowed region,
and 0.6% in disallowed region
a Rmerge =
P
hkl
P
ijI(hkl)i 2 <I(hkl)>j/PhklPi <I(hkl)i>.
b Rwork =
P
hkl jFo(hkl) 2Fc(hkl)j/
P
hkl jFo(hkl)j, where Fo and Fc are observed and calculated structure factors, respectively.
c Values indicate root-mean-square deviations in bond lengths and bond angles.
d Parentheses indicate statistics for the high-resolution bin.
e Friedel mates are considered as unique reflections.an attractive target for the development of therapeutic
interventions. Consistent with this notion, the adminis-
tration of NTB-A-Fc fusion protein delays the onset of
experimental autoimmune encephalomyelitis (EAE) in
a mouse model (Valdez et al., 2004).
Notably, the identified binding partners of the CD2-
family receptors are always member(s) of this same
family. Specifically, NTB-A, CRACC, CD84, SLAM, and
Ly-9 are homophilic receptors because they are self-
ligands, whereas CD48 and CD2 participate in hetero-
philic interactions with 2B4 and CD58, respectively
(Engel et al., 2003). The X-ray structures of CD2 (Bodian
et al., 1994; Jones et al., 1992), CD58 (Ikemizu et al.,
1999), and the CD2-CD58 heterophilic complex (Wang
et al., 1999), as well as the NMR structure of 2B4 (Ames
et al., 2005) have been reported. Despite the importance
of homophilic interactions within the SLAM family, there
are no data addressing several important issues, includ-
ing the structural similarities and differences between
homophilic and heterophilic interactions, a mechanistic
explanation for the wide range of affinities associated
with homophilic interactions, and the signal-transduc-
tion mechanisms utilized by the SLAM-family receptors.
We report the structural, biophysical, and biochemical
analyses of the complete ectodomain of human NTB-A.In solution, NTB-A exists as a dimer characterized by an
equilibrium dissociation constant (KD) of w2 mM. The
NTB-A crystal structure revealed a highly kinked dimer,
composed of rod-like monomers, that spans w100 A˚.
The homophilic interface was formed by the nearly or-
thogonal association of the front b strands from the IgV
domains of two engaging molecules and exhibited phys-
icochemical properties that differ significantly from
those observed in the CD2-CD58 heterophilic interface.
The crystallographically observed homophilic interface
was confirmed by a series of mutagenesis and biochem-
ical experiments and may serve as a structural paradigm
for homophilic interactions within the SLAM family. The
present structure also places strong physical con-
straints on the behavior of the NTB-A molecule and has
implications for NTB-A localization and signaling within
the immunological synapse.
Results
Overall Structure
The final model has been refined to an Rwork and Rfree of
21.6% and 26.6%, respectively (Table 1). The asymmet-
ric unit contains four NTB-A molecules (denoted as A,
B, C, and D), all of which exhibit similar interactions
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561between the N-terminal IgV and the C-terminal IgC2 do-
mains, and such interactions result in an overall rod-like
structure for the monomer with dimensions of w20 3
253 85 A˚3 (Figure 1). These monomers form two similar
dimers, in which the interfaces are formed by the nearly
orthogonal association of the C, C0, C0 0, and F strands
from the front sheets of two engaging IgV domains.
This organization results in a kinked dimer with an
end-to-end distance that spans w100 A˚ (Figures 2A
and 2B). Because the same set of residues contributes
to the homophilic interactions in the two independent di-
mers (Figure 2C and Table S1 in the Supplemental Data
available online), the subsequent discussion will focus
on the dimer formed by the A and B molecules.
The N-Terminal IgV Domain
The N-terminal domain of NTB-A is a two-layered b-
sheet structure, with the front face formed by the A0,
G, F, C, C0, and C0 0 strands and the back face formed
by the B, E, and D strands (Figure 1A); it was readily as-
signed to the V set of the immunoglobulin superfamily
(IgSF). Similar to all other CD2 family members, the
NTB-A IgV domain lacks the hallmark disulfide bond
that links the B and F strands in other IgSF domains.
The IgV domains of NTB-A and the related CD2, CD58,
and 2B4 receptors adopt a similar b-strand framework
despite a low sequence identity (Figure 3A). NTB-A
and CD2 (Wang et al., 1999) exhibit a root mean square
deviation (RMSD) ofw1.5 A˚ based on 86 equivalent Ca
atoms, confirming their structural similarity. Similarly,
NTB-A and 2B4 exhibit an RMSD of w2.2 A˚ (86 Ca)
(Ames et al., 2005), and NTB-A and CD58 exhibit an
RMSD of w1.7 A˚ (87 Ca) (Wang et al., 1999). Whereas
the overall disposition of the b strands of these IgV
domains is highly similar, the loops exhibit considerable
diversity in both length and orientation. Specifically,
NTB-A and 2B4 have longer C0C0 0 and CC0 loops, respec-
tively, whereas CD58 possesses a shorter FG loop. The
CC0 loop of 2B4 is almost coplanar with the front
b strands, resulting in a relatively flat front face. In con-
trast, the CC0 loop in CD2, NTB-A, and CD58 curves
away from the back sheets, resulting in more concave
front surfaces. These IgV domains also differ substan-
tially in the electrostatic properties of their front sur-
faces. CD58 and CD2 have a large number of acidic
and basic residues on their front sheets, respectively,
whereas both NTB-A and 2B4 have predominantly
neutral, albeit polar, front surfaces.
The IgC2 Domain
Prior to the present work, rat and human CD2 were the
only CD2 family members for which structures of both
the IgV and IgC2 domains were available (Bodian
et al., 1994; Jones et al., 1992). The overall b-strand to-
pology of the IgC2 domains is conserved between
NTB-A and CD2 (RMSD of w2.2–2.6 A˚), with the front
sheet formed by the G, F, C, and C0 strands and the
back sheet formed by the A, B, and E strands (Figure 3B).
The most notable differences are that the NTB-A IgC2
domain has longer AB and EF loops as well as a shorter
C0 strand and C0E loop compared to the CD2 IgC2 do-
mains. Notably, in addition to the presence of the
hallmark disulfide bond connecting the B and F strands
(Cys-131–Cys-173 in NTB-A), the IgC2 domains of allCD2-family receptors contain a second noncanonical
disulfide bond. In NTB-A, this additional disulfide bond
(Cys-125–Cys-192) tethers the beginning of the B strand
and the C terminus of the IgC2 domain, whereas in CD2,
it links the end of the A strand to the C terminus of the
IgC2 domain.
The IgV-IgC2 Interface
The overall rod-like architecture of the NTB-A monomer
is the consequence of specific interactions between the
IgV and IgC2 domains (Figure 1B). The G strand from the
IgV domain ends at Leu-105 and is followed by a five-
residue tether (106RQLRN110) that connects the two
domains. Comparison of the four NTB-A molecules
showed that the interdomain angles formed by the IgV
and IgC2 domains range from w120–134. This struc-
tural plasticity is reminiscent of that present in rat CD2,
where the interdomain angles of two independent mole-
cules differ by 7 (Jones et al., 1992). The human and rat
CD2 structures exhibit interdomain angles ofw160 and
w140–147, respectively, which are larger than that of
human NTB-A. This difference in interdomain angle is
best appreciated by superimposition of the IgV domains
of NTB-A and CD2 and observation of the dramatic
deviation in the placement of the IgC2 domains
(Figure 3C). The IgV-IgC2 domain interface of NTB-A is
stabilized byw589–671 A˚2 of total buried surface area,
comparable to the 585–627 A˚2 of buried surface area in
rat and human CD2. Four residues from the IgV domain
(Asn-9, Ile-11, Leu-12, and Leu-105), two residues from
the tether region (Arg-106 and Gln-107) and three resi-
dues from the IgC2 domain (Asn-177, Ala-178, and
Val-179) account for w80% of the total buried surface
area at the IgV-IgC2 interface in NTB-A (Table S2). In
addition to the considerable van der Waals contacts
involving these residues, a hydrogen bond formed by
the main-chain oxygen of Arg-106 and Asn-177 ND2
Figure 1. Organization of the NTB-A Monomer
(A) The NTB-A ectodomain consists of membrane-distal IgV and
membrane-proximal IgC2 domains. The b strands are labeled and
the potential N-glycosylation sites are highlighted.
(B) The interdomain interface is stabilized by a number of van der
Waals interactions and an invariant hydrogen bond involving
Asn-177 ND2 and the main-chain oxygen of Arg-106 (black dash
line). Asn-177 OD1 also forms potential hydrogen bonds with
main-chain nitrogen atoms in the FG loop.
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562Figure 2. Organization of the NTB-A Homophilic Dimer
(A) The NTB-A dimer is composed of two monomers, shown as blue and red, which interact in a nearly orthogonal fashion and result in an end-
to-end distance ofw100 A˚.
(B) Expanded view along the local two-fold symmetry axis of the interface, showing the orthogonal association of the front b sheets with
predominant contributions from the C, C0, C0 0, and F strands of each monomer.
(C) Detailed view of the NTB-A homophilic interface. In the left panel, residues forming hydrogen bonds, as well as Phe-42 that marks the
approximate center, are shown at same orientation as (B); hydrogen bonds are represented by dashed lines. In the right panel, the dimer is
rotatedw180 along the indicated axis so that the hydrophobic interactions involving aromatic residues at the interface are best illustrated.
(D) Alignment of NTB-A ectodomain sequences. The conserved residues are shaded red, and residues with similar properties are labeled red.
Residues involved in homophilic and interdomain interactions are denoted ‘‘*’’ and ‘‘B’’, respectively. The b strands are denoted as underlined
segments in the human sequence and labeled with black (IgV) and red (IgC2) letters.connects the tether region and FG loop of the IgC2
domain (Figure 1B and Table S2).
The NTB-A Homophilic Interface
The NTB-A homophilic interface is formed by the nearly
orthogonal association of front b strands from the two
engaging IgV domains and buries a total surface area
ofw1583 A˚2. As expected, the NTB-A homophilic inter-
face displays rough two-fold symmetry (Figures 2B and
2C). Twelve residues (Glu-37, Ser-39, Thr-56, Arg-86,
Gln-88, Ser-90, and their symmetry mates) are involvedin the formation of eleven potential hydrogen bonds
(Table S1); the side chains of Arg-86, Gln-88, and Ser-
90, contributed from the F strand of one NTB-A mole-
cule, make potential hydrogen bonds with main-chain
atoms of Glu-37, Ser-39/Thr-56 and Thr-56 from the
partner molecule, respectively (Figure 2C). van der
Waals contacts also make important contributions,
with Leu-34 and Phe-42 near the center of the homo-
philic interface making hydrophobic interactions with
Leu-34 and Phe-42 from the opposing molecule, respec-
tively. Four additional hydrophobic interactions are
Structural Basis of NTB-A Homophilic Interaction
563provided by intermolecular contacts between Phe-30
and His-54, between Phe-42 and His-54, and their
symmetry related interactions (Figure 2C and Table
S1). Notably, modeling of all potential N glycans onto
the NTB-A structure is consistent with the observed
homophilic interaction.
Of the residues that contribute to the human NTB-A
homophilic interface, only two appear to be fully con-
served (Figure 2D). This somewhat surprising lack of
sequence conservation may be explained by the local-
ized conservation of functionality. Of the three F-strand
residues (Arg-86, Gln-88, and Ser-90) whose side chains
serve as hydrogen donors and acceptors, only Gln-88 is
fully conserved. The replacement of Ser-90 with Thr in
bovine and mouse is not expected to substantially affect
hydrogen bonding interactions. In addition, Arg-86 is
present in both human and bovine, suggesting that
a similar side-chain-to-main-chain hydrogen bond is
conserved. In the murine protein, Arg-86 is replaced by
Figure 3. Structural Comparisons of NTB-A and Other CD2 Family
Members
(A) Superposition of IgV domains of CD2, NTB-A, 2B4, and CD58. The
loops exhibiting significant diversity are highlighted; the C0C0 0 and
CC0 loops are labeled with arrows and arrowheads, respectively.
(B) Comparison of the IgC2 domains of NTB-A and CD2. The loops
that exhibit significant structural deviations are indicated: the AB,
C0E, and EF loops are denoted by black arrows, pink arrowheads,
and black arrowheads, respectively. Disulfide bonds are highlighted
as magenta sticks.
(C) The difference in the NTB-A and CD2 interdomain angle is high-
lighted by superposition of the IgV domains, and such superposition
results in a significant deviation in the placement of IgC2 domains.Thr; however, modeling suggests that the equivalent of
human Glu-37 (murine Gln-41) may adopt a side-chain
conformation that supports hydrogen bonding interac-
tion(s) with this Thr. It therefore appears that the general
local arrangement of hydrogen bonding interactions is
conserved among these three species. Furthermore,
the localization of some critical van der Waals contacts
also seems to be conserved. For example, Phe-42,
which resides at the center of the homophilic interface,
interacts with Phe-42 from the partner molecule in hu-
man NTB-A. This hydrophobic stacking interaction is
fully conserved in the bovine protein and is likely re-
placed by a Val-Val hydrophobic interaction in the
murine protein. Collectively, these observations demon-
strate the local conservation of critical interfacial con-
tacts, despite the relatively low sequence identity at
the NTB-A homophilic interface.
The NTB-A Ectodomain Exists as a Homophilic
Dimer in Solution
Although NTB-A existed as a homodimer in crystalline
form, its oligomeric state in solution required further
examination. The purified ectodomain of human NTB-
A migrated as a symmetric monodisperse peak on a cali-
brated Superdex G200 gel-filtration column, with an
elution volume of 14.7 ml corresponding to an apparent
molecular weight (MW) between ovalbumin (43 kD) and
albumin (67 kD) (Figure 4A). The calculated MW of the
NTB-A monomer is w21.6 kD, suggesting that NTB-A
existed as an extended dimer or possibly a trimer. The
oligomeric state of NTB-A was further analyzed by sed-
imentation velocity analysis. A g(s*) analysis of the data
indicated that the average sedimentation coefficients
increased with loading concentration and demonstrated
that NTB-A reversibly self-associates (Figure 4B). How-
ever, sedimentation coefficients did not increase appre-
ciably above 0.34 mg/ml, suggesting relatively strong
association. The data were globally analyzed by direct
fitting of the sedimentation-velocity profiles with finite
element solutions of the Lamm equation. The data
were best fit by a model describing a monomer-dimer
self-association with a KD of w2 mM. These data were
poorly fit by the model of a single ideal species. Thus,
NTB-A exists as a fairly tight reversible noncovalent
dimer in solution, with no indication of higher-order
oligomerization.
Confirmation of the Crystallographically Observed
Homophilic Interface
For confirming the homophilic interface observed in the
crystalline state, a series of mutagenesis studies was
performed. All mutants (F30A, L34A, E37A, S39A,
F42A, H54A, T56A, R86A, Q88A, S90A in the putative in-
terface, and S94A outside the putative interface) were
expressed, refolded, and purified at yields comparable
to the wild-type protein, with the exception of the
F42A, E37A, and H54A mutants. E37A and H54A had sig-
nificantly lower refolding efficiencies but were reason-
ably stable after purification and suitable for gel filtration
analysis. F42A could not be refolded. Wild-type and mu-
tant proteins were examined on a calibrated Superdex
G200 column, and all mutants except S39A and S94A
exhibited a substantial increase in elution volume;
such an increase corresponds to a decrease in apparent
Immunity
564MW compared to the wild-type protein (Figure S1). As
main-chain oxygen and nitrogen atoms of Ser-39 form
hydrogen bonds with Gln-88 NE2 and OE1, respectively,
alteration of this side chain was not expected to disrupt
these hydrogen bonds. Although the side chain of Ser-
39 makes van der Waals contacts with Gln-88, the effect
of the S39A mutation on van der Waals interactions was
also predicted to be small because Ala and Ser have
grossly similar steric properties. It was thus not surpris-
ing that the S39A mutant exhibited chromatographic
behavior similar to the wild-type protein (Figure S1C).
E37A and T56A were also predicted to minimally affect
hydrogen-bonding interactions because only main-chain
atoms of these residues are involved. However, Glu-37
and Thr-56 are strongly buried at the homophilic inter-
Figure 4. Oligomeric States of the Wild-Type and S90A NTB-A
Ectodomains
(A) Elution profile of the human NTB-A ectodomain from Superdex
G200. The single monodisperse peak at 14.7 ml corresponds to
a MW between 43 and 67 kD.
(B) g(s*) analysis of the wild-type NTB-A by sedimentation velocity.
Protein concentration ranges from 0.14–1.38 mg/ml.
(C) g(s*) analysis of S90A by sedimentation velocity. Protein concen-
tration ranges from 0.17– 1.48 mg/ml.face, making extensive van der Waals contacts with
Leu-34/Arg-86 and Phe-30/Phe-42/Gln-88 from the op-
posing molecule, respectively. It is plausible that substi-
tutions of Glu-37 and Thr-56 to Ala would adversely
affect the homophilic interface because of the reduced
van der Waals contacts, consistent with the experimen-
tal results (Figure S1A).
Hydrogen bonds involving Arg-86, Gln-88, and Ser-90
appear to make significant contributions to the stability
of the homophilic interface because the R86A, Q88A,
and S90A mutants each exhibited decreased apparent
MW as shown by gel filtration (Figure S1B). Phe-30,
Leu-34, and His-54 also make significant contributions
to the homophilic interface, with more than half of their
total accessible area being buried (Table S1). Replace-
ment of these bulky side chains with Ala likely removed
critical van der Waals interactions and resulted in desta-
bilization of the NTB-A dimer in solution (Figures S1A
and S1B). As expected, the S94A mutation, which is
located outside the binding interface, behaved similarly
to the wild-type protein (Figure S1C).
For further confirmation of the crystallographically
observed interface, sedimentation-velocity analysis
was performed with purified S90A mutant protein. As
for the wild-type protein, data from the mutant protein
were best fit by a model of a monomer-dimer self-asso-
ciation. However, consistent with its chromatographic
behavior, the sedimentation coefficients for S90A con-
tinued to increase up to 1.48 mg/ml, suggesting
a weak association. The KD for the S90A mutant deter-
mined by global analysis is 32 mM compared to 2 mM
for the wild-type protein. Taken together, the mutagen-
esis experiments confirmed the contributions of several
specific residues and supported the crystallographically
observed homophilic interface.
Comparison of the NTB-A Homophilic and CD2-CD58
Heterophilic Dimers
The NTB-A homophilic and CD2-CD58 heterophilic di-
mers show overall similarities, with their interfaces
formed by the front sheets of the interacting IgV do-
mains. However, there are significant differences, which
are best appreciated by superimposition of one NTB-A
molecule and CD58 and observation of the deviation in
the placement of the second NTB-A molecule and CD2
(Figures 5A and 5C). The NTB-A homophilic interface is
formed by the nearly orthogonal association of front
b strands, whereas CD2 and CD58 contact each other
at a slightly larger angle and exhibit a translation with
respect to one another, as compared to the two-fold
symmetric NTB-A dimer. In the NTB-A dimer, the C0 0
strands and a single residue in each C0 0D loop are buried
at the homphilic interface. In contrast, in the CD2-CD58
heterodimer, only the analogous strand and loop from
CD58 contribute to the heterophilic interface. As a further
result of differences in relative subunit orientations, the
CD2-CD58 heterophilic interface involves a considerable
number of residues contributed from the CC0, C0C0 0, and
FG loops of both CD2 and CD58, whereas the NTB-A
homophilic interface is formed predominantly by strand-
to-strand contacts involving the C, C0, C0 0, and F strands
(Figures 5B and 5D).
The NTB-A dimer is stabilized by a slightly larger total
buried surface area than the CD2-CD58 dimer (i.e., of
Structural Basis of NTB-A Homophilic Interaction
5651583 A˚2 versus 1422 A˚2). The NTB-A dimer also exhibits
better surface complementarity (sc) compared to the
CD2-CD58 dimer as shown by a larger sc value for the
NTB-A dimer (0.68) than the CD2-CD58 heterodimer
(0.56). In addition, the physicochemical compositions
of two interfaces differ. The NTB-A interface is predom-
inantly stabilized by noncharged hydrogen bonds and
van der Waals contacts and thus contrasts with the
preponderance of ionic interactions present in the
CD2-CD58 interface (Wang et al., 1999). Despite these
significant differences, the NTB-A and CD2-CD58 di-
mers are characterized by roughly similar KDs ofw2 mM
and 10 mM (van der Merwe et al., 1994), respectively.
Discussion
It has been suggested that the CD2 family of receptors
arose via successive duplication events. In combination
with previous studies, the current NTB-A structure high-
lights a number of features conserved within the CD2
family and provides structural evidence supporting the
gene-duplication hypothesis. All CD2-family receptors
lack the characteristic disulfide bond that tethers the B
and F strands in their IgV domains. In addition, classical
IgV domains start with the A strand, followed by the A0
strand, and they hydrogen bond to the B and G strands,
respectively. Direct structural analysis demonstrates
that NTB-A, CD2, CD58, and 2B4 all lack the A strand.
Moreover, in the IgC2 domains, in addition to the hall-
mark intersheet disulfide bond between the B and F
strands, a second disulfide bond that bridges the end
of the A strand (CD2 and CD58) or the beginning of the
B strand (CD48 and all SLAM-family receptors) to the
end of the G strand is present. All CD2-family receptors
harbor a potential N-glycosylation site in the AB loop of
the IgC2 domain, except CD48 and 2B4 that bear
a potential N-glycosylation site at the nearby EF loop.
Finally, the CD2-CD58 heterophilic and NTB-A homo-
philic dimers exhibit gross overall structural similarity,
with their interfaces formed by the front sheets of the
IgV domains, suggesting that all CD2 family members
share a common organization that is relevant to function
(see below).
Sequence alignment of the homophilic receptors in
the SLAM family indicates that the covalent structures
of their IgV domains are very similar (i.e., there are few
insertions/deletions). Therefore, the current structure
serves as a possible template to model these homo-
philic interactions and provides insight regarding the
structural determinants responsible for specificity.
In human NTB-A, Arg-86, Gln-88 and Ser-90, which are
contributed from the F strand, all utilize side-chain func-
tionalities to participate in potential hydrogen bonds in
which main-chain atoms serve as a donor or acceptor.
The recognition of invariant main-chain atoms makes
these residues particularly amenable to substitution,
and the equivalent residues in CD84, Ly-9, and CRACC
are all capable of participating in hydrogen-bond inter-
actions through their side chains. The sole exception is
Gly-85 in CRACC; this is equivalent to Gln-88 in human
NTB-A. Accordingly, we postulate that these residues
in the F strand are of crucial importance for homophilic
interactions in CD84, Ly-9, and CRACC as well. Further-
more, the Phe-42–Phe-42 hydrophobic stacking interac-tion, which appears to mark the center of the homophilic
interface in NTB-A, is conserved in Ly-9 and is replaced
by the highly conservative Tyr-Tyr pair in CD84.
SLAM is distantly related to NTB-A, CRACC, CD84,
and Ly-9, as suggested by w20% sequence homology
between SLAM and each of these homophilic receptors.
Notably, the SLAM IgV domain lacks the intersheet hy-
drogen bond formed by the conserved Trp33 NE2 in
the middle of the C strand and the main-chain carbonyl
of a residue preceding the E strand; this bond is present
in almost all other IgV domains. Moreover, the KD for the
SLAM homophilic interaction is w200 mM (Mavaddat
et al., 2000), at least two orders of magnitude weaker
than other homophilic SLAM family members examined
to date. In light of this modest KD, it is tempting to spec-
ulate that additional binding partner(s) for SLAM remain
to be identified. Both sequence divergence and its
unique biochemical properties set SLAM apart as a dis-
tinct homophilic receptor in the SLAM family.
Interestingly, a recent study (Romero et al., 2005) indi-
cated that in Ly-9 the R44A mutation (the equivalent of
NTB-A Val-44), which is predicted to reside near the cen-
ter of the homophilic interface, resulted in an enhanced
homophilic association. This effect may be due to the
elimination of the unfavorable repulsive electrostatics
resulting from the close proximity of these two Arg
side chains in the Ly-9 homophilic interface. This obser-
vation highlights the critical concept that receptor-
ligand interactions do not evolve to produce the highest
possible affinity but instead evolve to select the affinity
that allows for the specificity, kinetics, and associated
signaling properties that are biologically optimal. Thus,
the specific differences in the SLAM-family-receptor
interfaces are likely to serve a number of important
biological functions, including the realization of biologi-
cally relevant KD values that span at least three orders of
magnitude. Specifically, the KDs for NTB-A and SLAM
arew2 mM and 200 mM, respectively, whereas the disso-
ciation of CD84 was undetectable by sedimentation-
velocity analysis (Q.Y., unpublished data), consistent
with a KD in the nM range. This observation suggests
that, analogous to the dwell time associated with TCR-
MHC interactions (Kalergis et al., 2001), affinity might
be an important determinant of the distinct functions as-
sociated with the different SLAM-family homophilic re-
ceptors. Furthermore, the divergence of interfacial resi-
dues provides unique determinants that promote the
specificity of each particular homophilic interaction
and interfere with inappropriate heterodimerization
among the family members.
The NTB-A mutagenesis studies highlight some po-
tentially important general principles that are relevant
to homophilic interactions within the SLAM family. The
S90A mutation in the NTB-A homophilic interface caused
aw15 fold increase in KD (lower affinity) compared to the
wild-type protein and thus resulted in a significant
monomer population in solution. In addition, other single
mutations (F30A, L34A, E37A, H54A, T56A, R86A, and
Q88A) all dramatically affected the homophilic associa-
tion and resulted in a predominantly monomer popula-
tion as judged by gel filtration. Taken together, these
data suggest that, despite the large homophilic inter-
face, the basis of specificity of homophilic interactions
in the SLAM family may be subtle because the change
Immunity
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567Figure 6. Functional Implications of the NTB-A Structure
Homophilic engagement of NTB-A may trigger recruitment of the NTB-A to the immunological synapse. The linear dimensions of the NTB-A
dimer are similar to those of other molecular signaling pairs involved in T cell regulation, consistent with a sorting mechanism based on molecular
extent. In T cells, the local enrichment of NTB-A and its associated signaling components, including SAP and FynT, initiates the downstream
signaling events that culminate in modulation of IFN-g secretion and stimulation of Th2 responses. In APCs, EAT-2-coupled signaling cascades
are similarly activated upon NTB-A homophilic engagement, although all of the analogous signaling molecules remain to be identified.of only a few (or single) residues may significantly alter
the monomer-dimer equilibrium. This apparent sensitiv-
ity may be related to the two-fold symmetric organization
of the homphilic dimer because a single mutation in the
primary sequence typically results in the disruption of
two sets of contacts at the binding interface. This sensi-
tivity might also represent an evolutionary mechanism
for the efficient generation of new functional receptors
with novel recognition properties.
A number of intrinsic structural features are relevant to
the physiological function of the CD2 family. The experi-
mentally determined interfaces suggest that, with the ex-
ception of Ly-9, all members of the CD2 family will exhibit
a similar overall organization with maximal linear dimen-
sions of w100–140A˚ (Figure 6). It has been speculated
that the unique compartmentalization of molecules
observed at the immunological synapse is driven by
a sorting mechanism based on molecular dimension.
Notably, the proposed CD2-family-receptor dimensions
are consistent with those of other pairs of signaling
molecules, including the TCR-pMHC and CTLA-4-B7complexes, that localize at the central zone of the immu-
nological synapse (van der Merwe et al., 2000).
The common molecular dimensions may be of partic-
ular relevance to the SLAM-family receptors because it
affords the opportunity for all homophilic- and hetero-
philic-receptor pairs to colocalize with the same set of
signaling molecules. These molecules are likely to ex-
hibit overlapping but unique functions because they
have distinct cytoplasmic domains with different signal-
ing. The ability of the family members to colocalize with
a common set of signaling partners could allow for the
subtle modulation of signaling mechanisms under a vari-
ety of stimuli in different cell types. Consistent with this
notion, several CD2 family members such as CD2 (van
der Merwe et al., 2000), CD48 (Moran and Miceli,
1998), and also the SAP adaptor protein (Cannons
et al., 2004), are recruited to the immunological synapse
formed between T cells and antigen-presenting cells
(APCs). Additionally, 2B4 and SAP are recruited to the
immunological synapse formed at the NK-target cell in-
terface (Roda-Navarro et al., 2004).Figure 5. Comparsion of Homophilic and Heterophilic Interfaces
(A and C) The overall organization of NTB-A homophilic and CD2-CD58 heterophilic dimers. One NTB-A molecule (blue) and CD58 (blue) are dis-
played in the same orientation, highlighting the detailed differences in overall organization of the two dimers. Residues contributing to the two
interfaces are highlighted yellow.
(B) Detailed view of the NTB-A homophilic interface. The blue monomer is rotatedw180 about a horizontal axis relative to (A) so that the residues
that contribute to the binding surface are exposed. The labels of individual residues are color coded blue, red, and black to represent basic,
acidic, and neutral residues, respectively.
(D) Residues contributing to the CD2-CD58 interface displayed as in (C). The significant contribution of loop residues and charged residues, rel-
ative to NTB-A, is demonstrated.
(E) Alignment of the CD2-family ectodomain sequences. The strictly conserved residues are shaded red, and residues with similar properties are
labeled red. Residues critical for homophilic interactions in NTB-A are denoted with ‘‘*’’, residues involved in CD2-CD58 heterophilic interaction
are denoted with black ‘‘#’’ (CD2) and blue ‘‘#’’ (CD58), and residues contributing to the interdomain interface in NTB-A and CD2 are denoted with
‘‘B’’. Ly-9 Arg-44 is underlined in green. The b strands identified from existing structures are underlined in black, and labeled with black (IgV) or
red (IgC2) capital letters. Potential N-glycosylation sites in the AB and EF loops in the IgC2 domains are underlined red.
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sylation site at the base of their IgC2 domains and prox-
imal to the plasma membrane. As previously suggested
for CD2 and ICAM (Wang and Springer, 1998), the pres-
ence of such N glycans may provide important steric
constraints that bias the orientation of the rod-like
NTB-A molecule with respect to the membrane and
could be an important determinant for the proper pre-
sentation of the ligand-binding surface. Furthermore,
both NTB-A and CD2 exhibit some degree of intrinsic
flexibility in the tether region joining the IgV and IgC2
domains, and this region may be of general importance
for receptor-ligand interactions in a physiological con-
text (Davis et al., 2003). Unlike the protein-protein inter-
actions observed in solution, the in vivo interactions
between membrane-anchored receptors and ligands
are subjected to forces that oppose binding, including
cell migration and fluctuations in inter-membrane dis-
tance. The plasticity of the tether region could allow
these membrane-anchored cell-surface proteins to
adapt to the dynamic environment without rupturing
the receptor-ligand interface. In addition, the IgV-IgC2
interface is essential for maintaining the overall architec-
ture responsible for presentation of the ligand-binding
surface. The mechanisms that control the finely bal-
anced dynamics at the domain interface are likely to
be shared through the entire CD2 family. Notably,
comparison of the NTB-A structure with the full-length
CD2 structures revealed that the same set of equivalent
residues are involved in the interdomain interactions,
including Asn-177 in the FG loop, which forms the
same side-chain-to-main-chain hydrogen bonds in
these structures. Because Asn-177 is invariant, these
contacts are likely to be functionally relevant to the entire
family; in fact, these contacts are conserved in a large
number of IgC2 domains and are responsible for main-
taining the overall compact state of the domain. More-
over, a noncanonical disulfide bond is present at
the base of IgC2 domains of all CD2-family receptors.
This modification serves to tether the two b sheets. It
has also been previously suggested to stabilize this do-
main against forces experienced in vivo (Wang et al.,
1999).
Crystallographic analysis supports a model in which
the NTB-A ectodomain is a homophilic dimer. Solution
studies also indicated that the formation of the homo-
philic dimer did not lead to any higher oligomerization
state, suggesting that the ligand-induced oligomeriza-
tion proposed for the tumor necrosis factor receptor
(TNFR) and epidermal growth factor receptor (EGFR)
families is unlikely to be part of the signaling mechanism
utilized by NTB-A. Furthermore, the compact nature of
the IgSF domains does not readily appear to lend itself
to a structural reorganization that might facilitate signal-
ing. Instead we favor a model in which the homophilic
engagement triggers the redistribution of freely diffusing
NTB-A molecules to the immunological synapse, result-
ing in the local enrichment of NTB-A and its associated
signaling components, including the adaptor SAP. This
enrichment results in a series of localized and concerted
molecular activation events (e.g., phosphorylation),
which ultimately exceed an existing threshold and result
in modulation of IFN-g secretion and enhancement of
Th2 immune responses.Experimental Procedures
Cloning, Expression, and Purification of Human NTB-A
Ectodomain
The human NTB-A ectodomain (24-215 plus the initiator methionine)
and mutants (F30A, E37A, S39A, F42A, H54A, T56A, R86A, Q88A,
S90A, and S94A) were expressed from pET-3a in Rosseta (DE3)
pLysS E. coli strain. Selenomethionine (SeMet)-substituted protein
was produced in the methionine auxotroph B834 (DE3) E. coli strain.
All proteins were refolded as described for B7-2 (Zhang et al., 2002).
Proteins were purified by gel filtration and anion exchange chroma-
tography.
Sedimentation Velocity Analysis
Wild-type and S90A mutant NTB-A proteins were exchanged into
a buffer containing 20 mM Tris (pH 7.45) and 50 mM NaCl. Sedimen-
tation velocity analysis was performed at protein concentrations of
1.38, 1.0, 0.34, and 0.14 mg/ml for the wild-type protein and 1.48,
0.5, and 0.17 mg/ml for the S90A protein in a Beckman coulter
XL-I. Data were collected at 20C and 55,000 rpm, and interference
scans were acquired at 1 min intervals for 5 or 7 hr. Data were first
analyzed with the program DcDt+ (Philo, 2000). The KDs of the
homophilic interactions were obtained by global fitting of all the
data sets collected at different concentrations with sedanal (Stafford
and Sherwood, 2004) or sedphat (Schuck, 2003).
Structure Determination
NTB-A (4 mg/ml in 10 mM Tris [pH 8.5]) was crystallized by sitting
drop vapor diffusion with 2.5 ml of protein and 2.5 ml of precipitant
composed of 0.42–0.5 M CaCl2, 100 mM HEPES buffer (pH 7.4),
1.0 mM Pt(NH3)2Cl2, and 4% PEG400 at 4
C. SeMet-substituted
NTB-A was crystallized by microseeding with native crystals. Prior
to flash-cooling (100 K), crystals were cryoprotected in mother liquor
containing 25% PEG400 supplemented with 15% MPD. Native
(3.0 A˚) and MAD (3.3 A˚) data were collected at beam line X29 at
the National Synchrotron Light Source (NSLS) in Brookhaven Na-
tional Laboratory. Native and SeMet-substituted crystals exhibited
diffraction consistent with the space group C2; data were integrated
and scaled with HKL2000 (Otwinowski and Minor, 1997).
The heavy atom substructure was solved with SHELXD (Schneider
and Sheldrick, 2002) with peak data in the 40–3.7 A˚ resolution range;
phase determination and density modification with SOLVE (Terwil-
liger and Berendzen, 1999) and RESOLVE (Terwilliger, 2000), respec-
tively, were then performed. The main chain was manually built into
the electron density with programs O (Jones et al., 1991) and COOT
(Emsley and Cowtan, 2004) and then rigid body refinement and
simulated annealing with CNS were performed with native data
(Brunger et al., 1998). ARP/wARP was used so that the map together
with restraints from experimental phases could be further improved.
The model was further developed by alternate cycles of manual
revision and refinement with refmac5 (Murshudov et al., 1997). TLS
refinement was used in the final stages, and omit maps were calcu-
lated to check the accuracy of the model. The four molecules in the
asymmetric unit are denoted as A, B, C, and D. Electron density for
all the four molecules was continuous except for Gln-118–Phe-120,
Gln-118–Gln-121 in the AB loop of IgC2 domains of A and C mole-
cules, respectively. The IgV domain of the C molecule exhibited rel-
atively poor electron density throughout the entire refinement; this
may be explained by the relatively high solvent exposure of its
back face, although the electron density for residues in the homo-
philic interface was unambiguous. Residues in the generously al-
lowed and disallowed regions in the Ramachandran plot account
for 1.9% and 0.6% of the total residues, respectively; these residues
are predominately contributed from connecting loops, mostly from
C molecule.
Analysis of superpositions were performed with the CCP4 suite
(Mitchell et al., 1990; Potterton et al., 2002; Potterton et al., 2004).
Surface complementarities, accessible surface area, and atomic
contacts were calculated with the sc (Lawrence and Colman,
1993), areaimol (Lee and Richards, 1971), and contact (Skarzynski
T. and Leslie A.) programs in CCP4 Suite (CCP4, 1994), respectively.
Structure-based sequence alignment was rendered with the pro-
gram ESPript (Gouet et al., 1999). Ribbon diagrams were generated
with Pymol (DeLano W.L., http://pymol.sourceforge.net/). The
Structural Basis of NTB-A Homophilic Interaction
569modeling of N glycans was performed with GlyProt (Bohne-Lang
and von der Lieth, 2005).
Supplemental Data
Supplemental Data include one figure and two tables and can be
found with this article online at http://www.immunity.com/cgi/
content/full/25/4/559/DC1/.
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